The imperative for increased investment for an HIV cure.

Saved in:
Bibliographic Details
Title: The imperative for increased investment for an HIV cure.
Authors: van Leeuwen R; Aidsfonds-Soa Aids Nederland, 1014 AX Amsterdam, Netherlands. Electronic address: rvanleeuwen@soaaids.nl., Barré-Sinoussi F; Sidaction, Paris, France; Institut Pasteur, Université Paris Cité, Paris, France., Müller-Trutwin M; Institut Pasteur, Université Paris Cité, Paris, France., Sáez-Cirión A; Sidaction, Paris, France; Institut Pasteur, Université Paris Cité, Paris, France., Nijhuis M; University Medical Centre Utrecht, Spiral Research Consortium, Utrecht, Netherlands; HIV Pathogenesis Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa., Lewin SR; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection, Melbourne, VIC, Australia., Ndung'u T; Africa Health Research Institute, Durban, South Africa; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa; Ragon Institute of Massachusetts General, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA; Division of Infection and Immunity, University College London, London UK., Riako-Anam F; Global Network of People living with HIV, Johannesburg, South Africa., Warren M; AIDS Vaccine Advocacy Coalition, New York, NY, USA., Sikazwe I; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia; Africa HIV Cure Consortium, Lusaka, Zambia., Poniatowski B; International Aids Society, Geneva, Switzerland., Grinsztejn B; International Aids Society, Geneva, Switzerland; FIOCRUZ HIV/AIDS Service, Rio de Janeiro, Brazil., Kityo C; Joint Clinical Research Centre, Kampala, Uganda., Davis M; Funders Concerned About AIDS, Washington, DC, USA., Søgaard OS; Aarhus University Hospital, Aarhus, Denmark., Altfeld M; German Centre for Infectious Diseases Research, Leipzig, Germany; Leibniz-Institute of Virology, Leipzig, Germany., Martinez-Picado J; IrsiCaixa, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain; Catalan Institution for Research and Advanced Studies, Barcelona, Spain., Vandekerckhove L; Department of General Internal Medicine in the Ghent University Hospital, Ghent, Belgium., Gramatica A; amfAR, New York, NY, USA., Sok D; Global Health Investment Corporation, New York, NY, USA., Collins S; European AIDS Treatment Group, Brussels, Belgium; HIV i-Base, London, UK., Yazdanpanah Y; ANRS Emerging Infectious Diseases, Paris, France.
Source: The lancet. HIV [Lancet HIV] 2025 Oct; Vol. 12 (10), pp. e671-e673. Date of Electronic Publication: 2025 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2352-3018
DOI:10.1016/S2352-3018(25)00193-6